Today, the European Commission has proposed to subject the new psychoactive substance acryloylfentanyl to control measures across the European Union. According to the risk assessment report provided by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), acryloylfentanyl is a synthetic and potent opioid which may be easily abused and could lead to dependence. The substance is sold as a “research chemical”, typically as powder and ready-to-use nasal sprays, and can cause severe harm to health. So far, 47 deaths associated with acryloylfentanyl have been reported by 3 Member States, in addition to more than 20 acute intoxications. Commissioner for Migration, Home Affairs and Citizenship Dimitris Avramopoulos said: “The number, type and availability of harmful new drugs are constantly evolving and their spread across Europe cannot be effectively addressed by Member States on their own. Our proposal to make sure one more new substance undergoes adequate control measures across the EU is part of our efforts to put in place the right safeguards and support Member States in their fight against the rise of these very dangerous substances.” The Commission’s proposal will now be discussed by the Member States in the Council, which, in consultation with the European Parliament, will decide whether to adopt the measures.
